Alaunos Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Alaunos Therapeutics, Inc. (TCRT) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.02 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-07.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-07
- Alaunos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-12-31 was $228.00K.
- Alaunos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-09-30 was $788.00K.
- Alaunos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-09-30 was $60.75M.
- Alaunos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $1.02M.
- Alaunos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2007 was $5.43M, a 58.50% decline from fiscal 2006.
- Alaunos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2006 was $13.09M, a 677.90% increase from fiscal 2005.
- Alaunos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2005 was $1.68M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2021-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $1.02M derived: sum of 2 quarters · filed 2023-03-07 | $1.02M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $788.00K 10-Q · filed 2022-11-14 | $788.00K 10-Q · filed 2022-11-14 | ||
| 2019-09-30 | $60.75M 10-Q · filed 2020-11-05 | $60.75M 10-Q · filed 2020-11-05 | ||
| 2007-12-31 | $5.43M 10-K · filed 2014-03-03 | |||
| 2006-12-31 | $13.09M 10-K · filed 2014-03-03 | |||
| 2005-12-31 | $1.68M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |